SEGMENT INFORMATION - Segment Information Of Net Sales And Operating Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Segment Reporting Information [Line Items]
Net sales	$ 2,701	$ 2,625
Cost of sales	1,810	1,764
Selling, general and administrative expenses	728	703
Research and development expenses	139	140
Segment operating income	66	58
Operating Segments | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	1,285	1,262
Cost of sales	781	694
Selling, general and administrative expenses	290	286
Research and development expenses	54	59
Other segment items	(26)	(21)
Segment operating income	186	244
Operating Segments | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	705	704
Cost of sales	390	356
Selling, general and administrative expenses	209	217
Research and development expenses	49	45
Other segment items	(9)	(7)
Segment operating income	66	93
Operating Segments | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	621	581
Cost of sales	458	396
Selling, general and administrative expenses	102	103
Research and development expenses	22	26
Other segment items	(7)	(7)
Segment operating income	$ 46	$ 63